Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)
Technical Analysis Report for USA stock ALNY Alnylam Pharmaceuticals. Dated: 15 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Opened at 394.22 and Closed at: 391.50, which is -1.55% of previous session's close. It moved within a range of 390.00 and 402.33
The session was a Bearish session with an average volume of 1483300, which is -11.86% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 8 days back on short term averages
Support for tomorrow is 384.59 and resistance for tomorrow is 396.92
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 386.89, 382.28 resistance for tomorrow's hourly charts is 399.22, 406.94
10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 431.31 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 439.69 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 451.74 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 445.75 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Alnylam Pharmaceuticals is 361.85 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Alnylam Pharmaceuticals is at 439.69 and 200 DMA is at 361.85, while 50 DMA and 100 DMA are at 451.74 and 445.75 respectively
Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 439.69 and 20 EMA is at 432.94
| Date | Closing Price | 20 SMA | 20 EMA |
| 15 Mon Dec | 391.50 | 439.69 | 432.94 |
| 12 Fri Dec | 397.55 | 442.57 | 437.3 |
| 11 Thu Dec | 412.63 | 445.39 | 441.48 |
| 10 Wed Dec | 404.46 | 447.4 | 444.51 |
| 09 Tue Dec | 415.21 | 449.77 | 448.72 |
| 08 Mon Dec | 430.02 | 451.1 | 452.25 |
Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 451.74 and 50 EMA is at 441.87
| Date | Closing Price | 50 SMA | 50 EMA |
| 15 Mon Dec | 391.50 | 451.74 | 441.87 |
| 12 Fri Dec | 397.55 | 453.03 | 443.92 |
| 11 Thu Dec | 412.63 | 454.3 | 445.81 |
| 10 Wed Dec | 404.46 | 455.26 | 447.16 |
| 09 Tue Dec | 415.21 | 456.29 | 448.9 |
| 08 Mon Dec | 430.02 | 456.94 | 450.27 |
Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 445.75 and 100 EMA is at 425.82
| Date | Closing Price | 100 SMA | 100 EMA |
| 15 Mon Dec | 391.50 | 445.75 | 425.82 |
| 12 Fri Dec | 397.55 | 445.11 | 426.51 |
| 11 Thu Dec | 412.63 | 444.39 | 427.09 |
| 10 Wed Dec | 404.46 | 443.52 | 427.38 |
| 09 Tue Dec | 415.21 | 442.68 | 427.84 |
| 08 Mon Dec | 430.02 | 441.73 | 428.1 |
Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 361.85 and 200 EMA is at 382.68
| Date | Closing Price | 200 SMA | 200 EMA |
| 15 Mon Dec | 391.50 | 361.85 | 382.68 |
| 12 Fri Dec | 397.55 | 361.07 | 382.59 |
| 11 Thu Dec | 412.63 | 360.3 | 382.44 |
| 10 Wed Dec | 404.46 | 359.47 | 382.13 |
| 09 Tue Dec | 415.21 | 358.69 | 381.9 |
| 08 Mon Dec | 430.02 | 357.87 | 381.56 |
Perrigo Company has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Perrigo Company, about 9.68% more returns!
Nu Skin has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Nu Skin, about 25.4% more returns!
Globus Medical has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Globus Medical, about 18.41% more returns!
Cardinal Health has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Cardinal Health, about 11.97% more returns!
Alnylam Pharmaceuticals has performed better than Xoma Corporation in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Wave Life has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Wave Life, about 140.3% more returns!
Savara Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Savara Inc, about 72.37% more returns!
Solid Biosciences has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Solid Biosciences, about 46.56% more returns!
Pro Dex has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Pro Dex, about 58.79% more returns!
Karyopharm Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Karyopharm Therapeutics, about 30.88% more returns!
Kamada has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Kamada, about 20.98% more returns!
Orthopediatrics Corp has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 25.22% more returns!
Galapagos Nv has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Galapagos Nv, about 16.13% more returns!
Beyondspring Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Beyondspring Inc, about 12.06% more returns!
Astrazeneca Plc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Astrazeneca Plc, about 17.41% more returns!
Avadel Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Avadel Pharmaceuticals, about 8.04% more returns!
Ascendis Pharma has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Ascendis Pharma, about 13.46% more returns!
Anika Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Anika Therapeutics, about 14.16% more returns!
Alnylam Pharmaceuticals Technical analysis of indicators
Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Alnylam Pharmaceuticals in short term and the sell signal is strong.
Alnylam Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Alnylam Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 426.63 and Alnylam Pharmaceuticals ALNY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.
Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALNY Experts View which covers a lot of information including buying and selling signals
ALNY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


